| scholarly article | Q13442814 |
| P2093 | author name string | Thompson CB | |
| Yang H | |||
| Mao X | |||
| Leiden JM | |||
| Miesfeldt S | |||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 18216-18222 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities | |
| P478 | volume | 269 |
| Q24646455 | A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland |
| Q39658956 | Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors |
| Q42804345 | Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins |
| Q36560535 | Determinants of DNA-binding specificity of ETS-domain transcription factors |
| Q35620499 | Differentiation of carbon dioxide-sensing neurons in Caenorhabditis elegans requires the ETS-5 transcription factor |
| Q37362452 | EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells |
| Q33638434 | EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo |
| Q28307320 | Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells |
| Q42801552 | Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. |
| Q34109415 | Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma |
| Q28506247 | Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes |
| Q37397291 | Ewing sarcoma fusion protein EWSR1/FLI1 interacts with EWSR1 leading to mitotic defects in zebrafish embryos and human cell lines |
| Q37993924 | Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors. |
| Q35057457 | Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities |
| Q24517781 | Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation |
| Q37152828 | GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. |
| Q35917053 | Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family |
| Q37872764 | Genomic and biochemical insights into the specificity of ETS transcription factors |
| Q40016977 | Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis |
| Q46131586 | Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma |
| Q36365913 | Importance of low affinity Elf-1 sites in the regulation of lymphoid-specific inducible gene expression |
| Q41141104 | Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides |
| Q35158848 | Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters |
| Q36786777 | Microsatellites as EWS/FLI response elements in Ewing's sarcoma |
| Q41887497 | Microsatellites with macro-influence in ewing sarcoma |
| Q36673885 | Molecular alterations in pediatric sarcomas: potential targets for immunotherapy |
| Q33963039 | Negative and translation termination-dependent positive control of FLI-1 protein synthesis by conserved overlapping 5' upstream open reading frames in Fli-1 mRNA. |
| Q37272420 | Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer |
| Q39237435 | Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma. |
| Q38612055 | Progress in the molecular biology of ewing tumors. |
| Q35188770 | Promiscuous partnerships in Ewing's sarcoma |
| Q36287019 | RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships. |
| Q36562720 | Recent advances in the molecular pathogenesis of Ewing's sarcoma |
| Q34990559 | Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism |
| Q38605150 | Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth |
| Q24546126 | SRE elements are binding sites for the fusion protein EWS-FLI-1 |
| Q37305155 | The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis |
| Q33420364 | The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function |
| Q35927957 | The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein. |
| Q36825143 | The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice |
| Q33391783 | Thrombocytopenia in Mice Lacking the Carboxy-Terminal Regulatory Domain of the Ets Transcription Factor Fli1 |
| Q38293060 | Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins |
Search more.